Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Quon

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Oncotarget|September 9, 2017
Prediction of EGFR and KRAS mutation in non-small cell lung cancer using quantitative <sup>18</sup>F FDG-PET/CT metricsRyogo Minamimoto, Mehran Jamali, Olivier Gevaert, et al.
Head & Neck|April 28, 2015
Aberrant lymphatic drainage and risk for melanoma recurrence after negative sentinel node biopsy in middle-aged and older menAnthony H Kaveh, Nicole M Seminara, Melynda A Barnes, et al.
International Journal of Radiation Oncology, Biology, Physics|September 18, 2007
Metabolic tumor burden predicts for disease progression and death in lung cancerPercy Lee, Dilani K Weerasuriya, Philip W Lavori, et al.
Molecular Imaging and Biology|July 20, 2017
How to Provide Gadolinium-Free PET/MR Cancer Staging of Children and Young Adults in Less than 1 h: the Stanford ApproachAnne M Muehe, Ashok J Theruvath, Lillian Lai, et al.
Molecular Imaging and Biology|September 23, 2003
Conventional imaging and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of previously treated non-Hodgkin's lymphoma patientsJean-Emmanuel Filmont, Duska Vranjesevic, Andrew Quon, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2008
Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancerDevin Schellenberg, Karyn A Goodman, Florence Lee, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 15, 2024
FAPI PET uptake patterns after invasive medical interventions: a single center retrospective analysisPeter George Maliha, Masatoshi Hotta, Andrea Farolfi, et al.
Blood Neoplasia|July 30, 2025
Prognostic impact of extranodal disease on PET/CT in follicular lymphoma: results from a validation study with ECOG 2408Frederique St-Pierre, Stephen M Broski, Zequn Sun, et al.
Cancer Research|May 16, 2018
<i>GFPT2</i>-Expressing Cancer-Associated Fibroblasts Mediate Metabolic Reprogramming in Human Lung AdenocarcinomaWeiruo Zhang, Gina Bouchard, Alice Yu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2021
Safety of PSMA-Targeted Molecular Radioligand Therapy with <sup>177</sup>Lu-PSMA-617: Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312)Jeremie Calais, Johannes Czernin, Pan Thin, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Oncotarget|September 9, 2017
Prediction of EGFR and KRAS mutation in non-small cell lung cancer using quantitative <sup>18</sup>F FDG-PET/CT metricsRyogo Minamimoto, Mehran Jamali, Olivier Gevaert, et al.
Head & Neck|April 28, 2015
Aberrant lymphatic drainage and risk for melanoma recurrence after negative sentinel node biopsy in middle-aged and older menAnthony H Kaveh, Nicole M Seminara, Melynda A Barnes, et al.
International Journal of Radiation Oncology, Biology, Physics|September 18, 2007
Metabolic tumor burden predicts for disease progression and death in lung cancerPercy Lee, Dilani K Weerasuriya, Philip W Lavori, et al.
Molecular Imaging and Biology|July 20, 2017
How to Provide Gadolinium-Free PET/MR Cancer Staging of Children and Young Adults in Less than 1 h: the Stanford ApproachAnne M Muehe, Ashok J Theruvath, Lillian Lai, et al.
Molecular Imaging and Biology|September 23, 2003
Conventional imaging and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of previously treated non-Hodgkin's lymphoma patientsJean-Emmanuel Filmont, Duska Vranjesevic, Andrew Quon, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2008
Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancerDevin Schellenberg, Karyn A Goodman, Florence Lee, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 15, 2024
FAPI PET uptake patterns after invasive medical interventions: a single center retrospective analysisPeter George Maliha, Masatoshi Hotta, Andrea Farolfi, et al.
Blood Neoplasia|July 30, 2025
Prognostic impact of extranodal disease on PET/CT in follicular lymphoma: results from a validation study with ECOG 2408Frederique St-Pierre, Stephen M Broski, Zequn Sun, et al.
Cancer Research|May 16, 2018
<i>GFPT2</i>-Expressing Cancer-Associated Fibroblasts Mediate Metabolic Reprogramming in Human Lung AdenocarcinomaWeiruo Zhang, Gina Bouchard, Alice Yu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2021
Safety of PSMA-Targeted Molecular Radioligand Therapy with <sup>177</sup>Lu-PSMA-617: Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312)Jeremie Calais, Johannes Czernin, Pan Thin, et al.
Pageof 10